Antipodes Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Sell |
241
-14
| -5% | -$6.23K | ﹤0.01% | 73 |
|
|
2025
Q1 | $124K | Buy |
+255
| New | +$124K | ﹤0.01% | 68 |
|
|
2024
Q4 | – | Sell |
-127,853
| Closed | -$59.5M | – | 94 |
|
|
2024
Q3 | $59.5M | Buy |
127,853
+558
| +0.4% | +$260K | 2.06% | 22 |
|
|
2024
Q2 | $59.7M | Sell |
127,295
-62,105
| -33% | -$29.1M | 2.17% | 21 |
|
|
2024
Q1 | $78.2M | Buy |
189,400
+100,480
| +113% | +$41.5M | 2.47% | 19 |
|
|
2023
Q4 | $36.2M | Buy |
+88,920
| New | +$36.2M | 1.13% | 29 |
|